A 17-year-old from Michigan faced "certain death" after coming down with the vaping-linked lung illness regulators recently tied to vitamin E acetate oil. Patients who have double lung transplants have a median survival of seven years after surgery, but the boy's doctors anticipate he may be able to beat those odds.
from Kaiser Health News https://ift.tt/2OeLPqa
November 13, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: Advocates See Promise In Mass. Governor’s ‘Aggressive’ Plan To Revamp Health Care; Apple Joins Efforts To End Calif. Housing Crisis With $2.5B PledgeMedia outlets report on news from Massachusetts, California, Illinois, Wisconsin, Pennsylvania, Kansas, Louisiana, Idaho, and Iowa. from Kaiser Health News https://ift.tt/36wRVKQ … Read More
Different Takes: Warren’s Plans For ‘Medicare For All’ Bear No Resemblance To Reality; Warren’s Ideas Might Work, But Congress Wouldn’t Approve Them AnywayEditorial pages focus on the plan Elizabeth Warren released on funding "Medicare For All". from Kaiser Health News https://ift.tt/32ihJqp … Read More
Record Number Of Legionnaires’ Cases In 2018 Risk Lives, Cause Cleanup HeadachesCases of Legionnaires’ disease reached a record high in 2018 — a more than eight-fold increase since the numbers began to climb nearly two decades ago. The Centers for Disease Control and Prevention reported Monday 9,933 case… Read More
Viewpoints: Physicians Face Tough Decisions About Opioids When Treating Kids; Medical Evacuees Are New Refugees Of Climate Change, WildfiresOpinion writers weigh in on these health issues and others. from Kaiser Health News https://ift.tt/36zs7NS … Read More
Physician Goes Behind The Scenes To Write Compelling Story About Treating Patients With New Cancer Gene TherapyIlana Yurkiewicz, a physician and medical journalist at Stanford University, explains why CAR-T is only used in patients with certain cancers and tries to answer why they haven’t yet been shown to work against solid tumors in… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment